Tirzepatide 50mg

Description

The 50mg Tirzepatide vial serves high-volume research facilities and multi-study programs requiring sustained access to this dual GLP-1/GIP receptor agonist. This quantity supports longitudinal preclinical studies, repeated dosing protocols, and comparative metabolic research designs.

Third-party HPLC and MS/MS verified to 99%+ purity. COA provided with every lot.

For research use only. Not for human or veterinary consumption.